Goldman Sachs Future Health Care Equity ETF(GDOC)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL RECENCY
2-STAR RATING
Consider higher Upturn Star rating
BUY for 1 day
PROFIT SINCE LAST BUY
0.00%
LAST CLOSE
$38.15
10/28/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for GDOC

10/28/2026: GDOC (2-star) has a low Upturn Star Rating. Not recommended to BUY.

GDOC provides actively managed exposure to companies leading the future of healthcare, including innovators in medical technology and digital health. Its main strengths lie in the institutional research expertise of Goldman Sachs and a focus on high-growth thematic trends. It is best used as a satellite holding for long-term growth investors who seek to supplement broad healthcare exposure with targeted innovation. Primary risks include sector-specific regulatory volatility, concentration in growth-focused companies, and the potential for higher expenses compared to passive indices. Investors should monitor healthcare policy changes and technological adoption rates to evaluate the fund's ongoing thesis.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

ETF holdings, costs, diversification, valuation, risks, and market conditions provide supporting context about the fund.

Investor Fit

Investor styleFitWhy
Growth investorStrong fitThe fund specifically targets high-potential, innovative healthcare companies with long-term growth profiles.
Momentum investorStrong fit while signal remains positiveThis fund may capture price momentum in trending healthcare sub-sectors when industry innovation is favored.
Value investorWeak fitThe focus on future-oriented growth and innovation often involves higher valuations compared to mature value stocks.
Dividend/Income investorWeak fitThe strategy prioritizes capital appreciation over dividend yield, making it unsuitable for income-focused portfolios.
Low-risk investorWeak fitActive management in innovative healthcare sectors carries significant volatility and concentration risk.

Investor Profile

Ideal Investor Profile

The ideal investor is a long-term growth-oriented participant willing to accept higher volatility in exchange for specialized exposure to healthcare innovation.

Suitability

GDOC is best suited as a satellite holding in a diversified portfolio for long-term investors seeking active, thematic healthcare exposure.

Risk Profile

Risk factorLevelWhy it matters
VolatilityHighThe focus on innovative growth companies leads to higher price fluctuations compared to broad market indices.
Market riskMedium / highChanges in general equity market conditions directly impact the performance of all healthcare sub-sectors.
ConcentrationMedium / highThe fund is limited to the healthcare sector, increasing sensitivity to sector-specific regulatory or clinical developments.
Tracking/expenseMediumActive management fees and lack of index tracking may lead to underperformance compared to lower-cost passive options.
LiquidityMediumSome smaller, innovative healthcare holdings may experience wider bid-ask spreads during market downturns.
Business/sector qualityMedium / highExposure to early-stage or innovation-led firms inherently carries higher business risk than established healthcare giants.

Risk Analysis

Volatility

GDOC historically exhibits higher volatility than broad market healthcare ETFs due to its active and concentrated thematic focus.

Market Risk

The fund is highly sensitive to the healthcare sector's regulatory environment and macroeconomic shifts impacting growth-stock valuations.

What the ETF Owns

Exposure TypeExposureWeight (%)Retail Investor Read
SectorHealthcare Equipment & Supplies35This sector captures companies developing advanced medical devices and diagnostic tools essential for modern healthcare.
IndustryLife Sciences Tools & Services30These firms provide the infrastructure and technology necessary for pharmaceutical and biotech innovation.
IndustryHealthcare Technology/Digital Health25Digital health solutions are increasingly critical for improving patient outcomes and streamlining care delivery.
Cash/collateralCash and Cash Equivalents10A small cash position is maintained for liquidity requirements and tactical portfolio adjustments.

Price Behavior

Strong Uptrend
PRICE PATH

Strong Uptrend

The stock has maintained a strong upward price trend across the last three quarters.

Smooth
PRICE STABILITY

Smooth

The stock has moved along a generally orderly path with only modest fluctuations.

Analysis of Past Performance

Type ETF
Historic Profit 12.12%
Avg. Invested days 42
Today’s Advisory Consider higher Upturn Star rating
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 3.0
ETF Returns Performance Upturn Returns Performance icon 3.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 10/28/2026
Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.